Cargando…
GRP 78 antibodies are associated with clinical phenotype in neuromyelitis optica
BACKGROUND: We previously reported the association between blood–brain barrier (BBB) dysfunction and glucose‐regulated protein 78 (GRP 78) autoantibodies in neuromyelitis optica (NMO). OBJECTIVE: We clarify whether the BBB‐endothelial cell activation induced by immunoglobulin G (IgG) is associated w...
Autores principales: | Shimizu, Fumitaka, Takeshita, Yukio, Hamamoto, Yuka, Nishihara, Hideaki, Sano, Yasuteru, Honda, Masaya, Sato, Ryota, Maeda, Toshihiko, Takahashi, Toshiyuki, Fujikawa, Susumu, Kanda, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801168/ https://www.ncbi.nlm.nih.gov/pubmed/31568704 http://dx.doi.org/10.1002/acn3.50905 |
Ejemplares similares
-
Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica
por: Shimizu, Fumitaka, et al.
Publicado: (2015) -
GRP78 autoantibodies initiate the breakdown of the blood-brain barrier in neuromyelitis optica
por: Shimizu, Fumitaka, et al.
Publicado: (2017) -
Paraneoplastic Neuromyelitis Optica Spectrum Disorder Related to Glucose-regulated Protein 78 (GRP78) Autoantibodies in a Patient with Lynch Syndrome-associated Colorectal Cancer
por: Minomo, Shogo, et al.
Publicado: (2022) -
GRP78 Antibodies Are Associated With Blood-Brain Barrier Breakdown in Anti–Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disorder
por: Shimizu, Fumitaka, et al.
Publicado: (2021) -
Effects of neuromyelitis optica–IgG at the blood–brain barrier in vitro
por: Takeshita, Yukio, et al.
Publicado: (2016)